Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored

Journal of Transplantation

doi 10.1155/2017/5646858

Full Text

Abstract

Available in

Date

January 1, 2017

Authors

Fernando González

Elizabeth Arriagada

Natalia Gallardo

Publisher

Hindawi Limited

Related search

Genotype-Guided Tacrolimus Dosing in African-American Kidney Transplant Recipients

Pharmacogenomics Journal

Molecular Medicine

English

Short-Term Outcomes in Heart Transplant Recipients Treated With Generic Tacrolimus Compared to Prograf

Open Journal of Organ Transplant Surgery

English

Antibiotic Resistance Must Be Monitored, US Senate Is Told

Multidisciplinary

English

How Safe Is Conversion From Tacrolimus to Its Generic Drug?—A Single Center Experience

Open Journal of Nephrology

English

Evaluation of Allergy to Tacrolimus in Kidney Transplant Candidates and Recipients With a History of Macrolide Antibiotic Allergy

American Journal of Transplantation

Transplantation

English

It Must Be

English

Nonoperative Management of Splenic Injury in Closely Monitored Patients With Reduced Consciousness Is Safe and Feasible

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

Emergency Medicine

Intensive Care Medicine

English

532 Switching From Calcineurin Inhibitors to Belatacept Decreases Keratinocyte Carcinomas Incidence Rate in Kidney Transplant Recipients

Journal of Investigative Dermatology

Molecular Biology

English

Haemodynamics of Stable Renal Transplant Recipients

Clinical Science

English